PLATINUM INVESTMENT MANAGEMENT LTD - BLUEPRINT MEDICINES CORP ownership

BLUEPRINT MEDICINES CORP's ticker is BPMC and the CUSIP is 09627Y109. A total of 280 filers reported holding BLUEPRINT MEDICINES CORP in Q4 2021. The put-call ratio across all filers is 1.68 and the average weighting 0.2%.

Quarter-by-quarter ownership
PLATINUM INVESTMENT MANAGEMENT LTD ownership history of BLUEPRINT MEDICINES CORP
ValueSharesWeighting
Q3 2023$252,004
-92.9%
5,018
-91.1%
0.01%
-91.9%
Q2 2023$3,550,007
+40.5%
56,1710.0%0.12%
+39.8%
Q1 2023$2,527,133
+44.8%
56,171
+41.0%
0.09%
+31.3%
Q4 2022$1,745,478
-19.4%
39,842
+21.2%
0.07%
-25.6%
Q3 2022$2,165,000
+7.1%
32,862
-17.9%
0.09%
+18.4%
Q2 2022$2,021,000
+16.7%
40,004
+47.5%
0.08%
+43.4%
Q1 2022$1,732,000
-40.4%
27,1210.0%0.05%
-34.6%
Q4 2021$2,905,000
+4.2%
27,1210.0%0.08%
+2.5%
Q3 2021$2,788,000
+16.8%
27,1210.0%0.08%
+43.6%
Q2 2021$2,386,000
-9.5%
27,1210.0%0.06%
-6.8%
Q1 2021$2,637,000
-13.3%
27,1210.0%0.06%
-15.7%
Q4 2020$3,042,000
-17.0%
27,121
-31.4%
0.07%
-23.1%
Q3 2020$3,663,000
+18.9%
39,5110.0%0.09%
+30.0%
Q2 2020$3,082,000
+33.4%
39,5110.0%0.07%
+20.7%
Q1 2020$2,311,000
+51.0%
39,511
+106.9%
0.06%
+93.3%
Q4 2019$1,530,000
+63.5%
19,094
+49.8%
0.03%
+42.9%
Q3 2019$936,000
-22.1%
12,7460.0%0.02%
-25.0%
Q2 2019$1,202,000
+17.8%
12,7460.0%0.03%
+16.7%
Q1 2019$1,020,00012,7460.02%
Other shareholders
BLUEPRINT MEDICINES CORP shareholders Q4 2021
NameSharesValueWeighting ↓
Aquilo Capital Management, LLC 581,768$25,487,2569.57%
Casdin Capital, LLC 1,477,800$64,742,4185.02%
Nextech Invest Ltd. 188,228$8,246,2693.28%
DAFNA Capital Management LLC 261,235$11,444,7053.22%
Rock Springs Capital Management LP 1,891,510$82,867,0531.99%
HealthCor Management, L.P. 30,000$1,314,3001.20%
EFG Asset Management (North America) Corp. 110,853$4,766,6791.07%
Novo Holdings A/S 370,000$16,209,7001.01%
SECTORAL ASSET MANAGEMENT INC 115,900$5,077,5790.98%
EMERALD MUTUAL FUND ADVISERS TRUST 305,709$13,393,1110.83%
View complete list of BLUEPRINT MEDICINES CORP shareholders